Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Buy
453
+22
+5% +$10.2K ﹤0.01% 679
2026
Q1
$207K Sell
431
-19
-4% -$9.73K ﹤0.01% 684
2025
Q4
$253K Buy
450
+24
+6% +$13.6K ﹤0.01% 626
2025
Q3
$219K Sell
426
-16
-4% -$6.99K ﹤0.01% 592
2025
Q2
$139K Sell
442
-48
-10% -$14.4K ﹤0.01% 711
2025
Q1
$149K Buy
490
+203
+71% +$68.3K ﹤0.01% 641
2024
Q4
$95.3K Buy
287
+16
+6% +$5.43K ﹤0.01% 703
2024
Q3
$90.5K Buy
271
+178
+191% +$67.6K ﹤0.01% 722
2024
Q2
$38.3K Sell
93
-13
-12% -$5.15K ﹤0.01% 887
2024
Q1
$42.8K Sell
106
-177
-63% -$62.2K ﹤0.01% 861
2023
Q4
$86.7K Hold
283
﹤0.01% 733
2023
Q3
$68.5K Sell
283
-15
-5% -$3.84K ﹤0.01% 760
2023
Q2
$71.6K Sell
298
-16
-5% -$3.32K ﹤0.01% 762
2023
Q1
$59K Sell
314
-116
-27% -$24K ﹤0.01% 800
2022
Q4
$91K Sell
430
-80
-16% -$16K ﹤0.01% 724
2022
Q3
$80K Buy
510
+16
+3% +$2.55K ﹤0.01% 766
2022
Q2
$74K Buy
494
+67
+16% +$9.7K ﹤0.01% 810
2022
Q1
$70K Sell
427
-192
-31% -$31.7K ﹤0.01% 865
2021
Q4
$134K Buy
+619
New +$130K ﹤0.01% 747

Other funds holding MEDP

UMB Bank's MEDP Position: Q2 2026 in Review

UMB Bank increased its Medpace (MEDP) stake by 5.1% in Q2 2026, buying an estimated $10.2K and bringing the position to 453 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #679.

UMB Bank first reported a position in MEDP in Q4 2021 and has held it in 19 quarters since. The position peaked at $253K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • UMB Bank held 453 shares of Medpace worth $240K as of Q2 2026.
  • UMB Bank bought 22 Medpace shares in Q2 2026, an estimated $10.2K.
  • Medpace made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #679 holding.
  • UMB Bank first reported a position in Medpace in Q4 2021 and has held it in 19 quarters since.
  • UMB Bank's Medpace position peaked at $253K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.